b 555 873 (Medroxyprogesterone 5 mg)
Pill imprint b 555 873 has been identified as Medroxyprogesterone acetate 5 mg.
Medroxyprogesterone is used in the treatment of abnormal uterine bleeding; amenorrhea; birth control; endometrial hyperplasia, prophylaxis; endometrial cancer (and more), and belongs to the drug classes contraceptives, hormones/antineoplastics, progestins. Not for use in pregnancy. Medroxyprogesterone 5 mg is not subject to the Controlled Substances Act.
See also related documents.
- 5 mg
- 6.00 mm
- Prescription only
methylcellulose (15 mPa.s)
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|66336-0603||Dispensing Solutions Inc. (repackager)|
|23490-5857||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about medroxyprogesterone
- Medroxyprogesterone injectable suspension
- Medroxyprogesterone injectable suspension (subcutaneous)
- Medroxyprogesterone injection
- Medroxyprogesterone (Advanced Reading)
- Medroxyprogesterone Intramuscular (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.